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Programmed and damage aging theories have traditionally been conceived as stand-alone schools of thought. However, the p66Shc
adaptor protein has demonstrated that aging-regulating genes and reactive oxygen species (ROS) are closely interconnected, since
its absence modifies metabolic homeostasis by providing oxidative stress resistance and promoting longevity. p66Shc(−/−) mice are a
unique opportunity to further comprehend the bidirectional relationship between redox homeostasis and the imbalance of
mitochondrial biogenesis and dynamics during aging. This study shows that brain mitochondria of p66Shc(−/−) aged mice exhibit
a reduced alteration of redox balance with a decrease in both ROS generation and its detoxification activity. We also
demonstrate a strong link between reactive nitrogen species (RNS) and mitochondrial function, morphology, and biogenesis,
where low levels of ONOO− formation present in aged p66Shc(−/−) mouse brain prevent protein nitration, delaying the loss of
biological functions characteristic of the aging process. Sirt3 modulates age-associated mitochondrial biology and function via
lysine deacetylation of target proteins, and we show that its regulation depends on its nitration status and is benefited by the
improved NAD+/NADH ratio in aged p66Shc(−/−) brain mitochondria. Low levels of protein nitration and acetylation could
cause the metabolic homeostasis maintenance observed during aging in this group, thus increasing its lifespan.
1. Introduction
Aging is a multifactorial degenerative process that strongly
impacts the endocrinology and biochemistry of the brain
[1]. Mitochondrial function declines in the normal aging
process and increases the incidence of age-related disorders.
In accordance with the free radical theory of aging, this pro-
cess can be ascribed to the oxidative damage caused by the
generation of reactive oxygen species (ROS) derived from
mitochondrial respiration when O2 is partially reduced [2].
It has been demonstrated that electron transfer leakage
throughout themitochondrial respiratory chain is responsible
for the formation of most cellular ROS [3]. In this way, ROS
generation depends on mitochondrial activity [4], which by
itself can be perceived as a signal sensor and transducer in
various enzymatic and gene-mediatedphysiological and path-
ophysiological processes [5].
In addition, mitochondrial function and morphology are
also modulated by nitric oxide (NO) exposure. NO is a
relatively low reactive radical whose derivatives, such as
peroxynitrite (ONOO−), can cause nitrosative damage in bio-
molecules, proteosomic degradation failure, enzymatic activ-
ity inhibition, and overall interference of regulatory functions
[6]. These processes occur in aging, when the levels of ROS
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rise and superoxide anion (O2
−) conjugates with NO to cre-
ate reactive nitrogen species (RNS), and their products
nitrate (NO3
−), nitrite (NO2
−), and peroxynitrite (ONOO−),
which have demonstrated a direct role in cellular signaling,
vasodilation, immune response, and aging [7–9].
Alterations in ROS/RNS levels have been mechanistically
linked with changes in mitochondrial morphology in many
studies, suggesting a crosstalk between redox homeostasis
and mitochondrial dynamics [10]. Mitochondrial morphol-
ogy is regulated by continuous fusion and fission events that
are essential to maintaining normal mitochondrial function
[11]. These fusion/fission processes are finely regulated by
the mitochondrial fusion proteins optic atrophy 1 (Opa1),
mitofusins 1 and 2 (Mfn1 and Mfn2, resp.) and by the
mitochondrial fission proteins dynamin-related protein 1
(Drp1) and fission protein 1 (Fis1). High levels of ROS and
RNS, such as those measured in aging models, have been
associated with redox-induced posttranslational modifica-
tions (i.e., nitration or S-nitrosylation) in several of these pro-
teins and their binding targets, leading to mitochondrial
fragmentation [12–14].
Mitochondrial plasticity and density decrease with age,
and their capacity for mitochondrial biogenesis is reduced
owing to a redox-dependent decline of (peroxisome
proliferator-activated receptor γ-coactivator-1α) (PGC-1α)
activity [15–17]. PGC-1α is a transcriptional coactivator that
enhances the activity of specific transcription factors, in turn
coordinating the expression of key nuclear-encoded mito-
chondrial genes that are required for the proper functioning
of the organelle.
A link between mitochondrial biogenesis and mitochon-
drial morphology has been suggested by the fact that PGC-1α
regulates Mfn2 expression. Repression of Mfn2 in cells
decreases oxygen consumption, mitochondrial membrane
potential, and the expression of oxidative phosphorylation
proteins [17].
On the other hand, changes observed in the lysine acety-
lation profile of proteins or “acetylome” are related to normal
aging and age-related diseases [18]. Sirt3, a member of the
NAD+-dependent deacetylase family, is the most studied
mitochondrial sirtuin associated with metabolic homeostasis
maintenance. Sirt3 is considered a key element to delaying
the loss of biological functions during aging [19]. Recent
studies have shown that the acetylation levels of mouse mito-
chondrial proteins are modulated in fasting conditions or
during caloric restriction [20]. Additionally, an increase in
Sirt3 expression was observed in several tissues under these
conditions, suggesting an improvement in the protection
against ROS-induced aging [21–24]. SIRT3 stimulates
proteins participating in ATP generation, tricarboxylic acid
(TCA) cycle, and electron transport chain and stress
response [25, 26]. Further, it promotes mitochondrial bio-
genesis via PGC-1α-mediated inhibition of cellular ROS
and delays mitochondrial dynamic age imbalance, deacety-
lating Opa1 [27, 28].
In the last years, more cases of cooperation between ROS
and aging-regulating genes have been established in senes-
cence and aging development [29]. The adaptor protein
p66Shc is a genetic determinant of lifespan that regulates
ROS metabolism and cellular apoptosis. Faced with a stress
signal (growth factor, insulin receptor activation, excessive
radiation, or oxidative stress), PKCβ phosphorylates p66Shc
in Ser36, which translocates to mitochondria, oxidizes cyto-
chrome c in the intermembrane space, and prevents electron
transfer to cytochrome oxidase, resulting in a higher reduc-
tion level of complex III (ubiquinol and cytochromes b-c1)
[30]. The inhibition of electron free flow determines the
formation of semiubiquinone and the subsequent O2 mono-
electric reduction with O2
− formation, eventually dismutated
to hydrogen peroxide (H2O2) by MnSOD [31]. p66
Shc abla-
tion in mice is translated into a significant decrease in
mitochondria-produced ROS and a 30% increase in lifespan
[32]. These knockout mice for p66Shc (p66Shc(−/−)) have been
shown to be thinner, to exhibit an increased metabolic rate,
and to have less body fat than their wild-type littermates
[33]. And more remarkably, they have been described as an
animal model of healthy aging with better cognitive abilities
at adulthood in a spatial memory task and improved physical
performance at senescence [34]. The aim of this study is to
deepen the bidirectional relationship between redox homeo-
stasis and the imbalance of mitochondrial dynamics and
biogenesis in this model of healthy aging.
2. Materials and Methods
2.1. Mice and Ethics. Dr. P. G. Pellicci at the European
Institute of Oncology, Milan, kindly provided 129 p66Shc
knockout (p66Shc(−/−)) breeding pairs for this project. The
breeding stocks were backcrossed onto 129/SV mice. A col-
ony was maintained in the animal facility at the School of
Pharmacy and Biochemistry of the University of Buenos
Aires. Heterozygous Shc KO mice (p66Shc(+/−)) were mated
to produce the homozygous Shc KO (p66Shc(−/−)), and WT
control littermates were used for the study. Mice aged 3, 18,
and 24 months from both groups were housed in a
constant-temperature room (20–24°C) with a 12-hour dark/
12-hour light cycle, fed ad libitum with a standard diet and
free access to water. Animal experiments were performed in
accordance with the principles of laboratory animal care.
The Institutional Animal Care and Research Committee of
the University of Buenos Aires approved all animal proce-
dures. We made every possible effort to minimize animal suf-
fering and to reduce the number of animals used.
2.2. Mitochondrial Isolation. Mice were deeply anesthetized
using ketamine (50mg/kg) and sacrificed by cervical disloca-
tion. The brains were immediately extracted and homoge-
nized in MSHE buffer (0.22M mannitol, 70mM sucrose,
0.5mM EGTA, 2mM KHEPES). The homogenate was cen-
trifuged at 800g for 10min at 4°C. The supernatant was
transferred and centrifuged again at 10,000g for 10min at
4°C in a Sorvall centrifuge. The pellet containing mitochon-
dria was resuspended and isolated at 100,000g by Percoll
gradient centrifugation in an ultracentrifuge [35]. Fresh
mitochondria were used to determine membrane potential,
oxygen consumption, NO production, nNOS activity, and
NAD/NADH ratio. For complex activities, MnSOD and
catalase activity, and Western blotting determination,
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mitochondria were stored at −80°C and then subjected to
three freeze/thaw cycles followed by a homogenization step
by passage through a 29G hypodermic needle.
2.3. NOS Activity. Homogenate fractions of brain tissue from
control and KO (p66Shc−/−) mice were determined by conver-
sion from [3H] L-Arg to [3H] L-citrulline [36] in 50mM
potassium phosphate buffer, pH7.4, in the presence of
100 μM L-Arg, 0.1 μM [3H] L-Arg (NEN), 0.1mM NADPH,
0.3mM CaCl2, 0.1 μM calmodulin, 10 μM tetrahydrobiop-
terin, 1 μM flavin adenine dinucleotide, 1 μM flavin mono-
nucleotide, 50mM L-valine, and 1mg/mL protein. Specific
activity was calculated by subtracting the remaining activity
in the presence of the NOS inhibitor 5mM L-NMMA or
2mM ethylene glycol tetraacetic acid [37].
2.4. Mitochondrial H2O2 Production. Mitochondrial H2O2
production was monitored using a Hitachi F-2000 spectro-
fluorometer with excitation and emission wavelengths at
315 and 425nm, respectively [31]. The reaction medium,
potassium phosphate buffer (50mM) and 50mM L-valine,
was supplemented with 10mM succinate, 12.5 units/mL
horseradish peroxidase, 250M p-hydroxyphenylacetic acid,
and 0.15mg of mitochondrial protein per mL. Mitochondrial
preparations were supplemented with 1 μM Mn(III)tetra-
kis(4-benzoic acid) porphyrin (Cayman Chemical, Ann
Arbor, MI) and 0.2 μM antimycin A for a uniform maximal
H2O2 production rate [38].
2.5. Antioxidant Enzyme Activities. Mitochondrial Mn-SOD
activity was determined by inhibition of cytochrome c reduc-
tion at 550nm in 50mM potassium phosphate buffer/
0.1mM EDTA (pH7.8) at 25°C, and results were expressed
as pmoles SOD per mg of protein [39]. Catalase activity in
supernatants was determined by the decrease in H2O2
absorption at 240nm (ε240 = 41 μM−1 cm−1). The pseudo-
first reaction constant (k′) expressed as k′/mg protein was
calculated and then extrapolated to a calibration curve to
obtain U CAT/mg protein [40].
2.6. Oxygen Consumption Rate. Oxygen uptake was deter-
mined polarographically with a Clark-type electrode placed
in a 3mL chamber at 30°C, in a reaction medium consisting
of 0.23mM mannitol, 70mM sucrose, 30mM Tris-HCl,
4mM MgCl2, 5mM Na2HPO4-KH2PO4, and 1mM EDTA,
pH7.4, saturated with room air (225 μM O2) with 0.5–1mg
mitochondria protein/mL. Oxygen uptake was determined
using 6mM malate-glutamate or succinate as substrates in
the presence (state 3) or the absence (state 4) of a phosphate
acceptor (0.2mM ADP). Oxygen uptake was expressed in
nanogram atoms of oxygen per minute per milligram of pro-
tein. The respiratory control rate was calculated as state 3/
state 4 respiration rate. The P/O ratio was calculated as the
ratio of nmoles of added ADP per nanogram atoms of O2
utilized during state 3 [41, 42].
2.7. Mitochondrial Respiratory Chain Complex Activity. Nic-
otinamide adenine dinucleotide- and succinate-cytochrome c
reductase activities (complexes I–III and II–III, resp.) were
assayed by cytochrome c reduction at 550nm with a
Hitachi U3000 spectrophotometer (Hitachi, Tokyo, Japan)
at 30°C. Cytochrome oxidase activity (complex IV) was
determined by monitoring cytochrome c oxidation at
550 nm (ε550 = 21mM−1 × cm−1); the reaction rate was
measured as the pseudo-first-order reaction constant (k′)
and expressed as k′/min/mg protein [43].
2.8. Mitochondrial Membrane Potential (Ψ) and
Mitochondrial NO, ROS, and O2
− Production.Mitochondrial
membrane potential (Ψ) and mitochondrial NO, ROS, and
O2
− production were estimated by flow cytometry (FACSCa-
libur) using fluorescent dyes 3,3′-dihexyloxacarbocyanine
iodide (DiOC6) (200nM; Molecular Probes), DAF-FM
(10 μM; Molecular Probes) with 0.3mM L-arginine in the
presence and absence of the NOS inhibitor (3mML-NAME),
H2DCFDA (25 μM; Sigma-Aldrich), or MitoSOX (2.5 μM;
Molecular Probes), respectively. Fresh brain mitochondria
(50 μg protein/mL) were suspended in 0.5mL of respiration
buffer (120mM KCl, 5mM KH2PO4, 1mM EGTA, 3mM
HEPES, and 1mg/mL fatty acid-free BSA [pH7.4]). These
assays were performed in the dark at 37°C for 15min. After
the incubation period, mitochondria were centrifuged for
5min at 10,000g for pelleting and washing and then sus-
pended to record the fluorescence intensity.
2.9. NAD/NADHMitochondrial Ratio and ATP Content. The
NAD Cycling Enzyme Mix in Abcam NADH/NAD Quanti-
fication Kit was specifically used to recognize NADH/NAD+
in an enzyme cycling colorimetric reaction read at OD
450 nm in a colorimetric microplate reader. Total ATP con-
tent was determined in 10mg of fresh slice brain tissue based
on luciferase’s requirement for ATP in producing light
(emission maximum ~560nm at pH7.8) using the ATP bio-
luminescent assay kit (Molecular Probes).
2.10. SIRT3 Deacetylase Activity. SIRT3 deacetylase activity
was determined as described in Cayman’s SIRT3 direct fluo-
rescent screening assay kit (item no. 10011566). In a plate,
assay buffer, modified p53 acetylated peptide, recombinant
Sirt3, and NAD+ were incubated with increased concentra-
tions of ONOO− (100, 250, and 500 μM) or with purified
mitochondrial lysates, final volume 50 μL. Deacetylation
reactions were stopped after 2 h of incubation at room tem-
perature by adding 50 μL of stop solution. The fluorophore
release by deacetylation of the p53 peptide was analyzed with
a fluorometer using an excitation wavelength of 350–360nm
and an emission wavelength of 450–465nm [44].
2.11. Mitochondrial Morphology. Transmission electron
microscopy was performed in 90 nm sections from mouse
brains and fixed in 4% paraformaldehyde, 2% glutaralde-
hyde, and 5% sucrose in PBS, followed by 2h postfixation
in 1% osmium tetroxide and then 1h in uranyl acetate in
50% ethanol. Samples were washed with 50% ethanol and
dehydrated with a graded series of ethanol, clarified with
acetone, and embedded in Vestopal. Grids were prepared
and stained with uranyl acetate and lead citrate. Samples
were observed at 100 kV with a Zeiss EM 109T transmission
electron microscope (Zeiss, Oberkochen, Germany). The
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mitochondrial area and length were measured in 400 mito-
chondria per mouse using the ImageJ software. For the quan-
tification of mitochondrial morphology, we used the criteria
described in [45].
2.12. RNA Extraction, Quantitative Real-Time PCR, and
mtDNA Content. Total RNA was extracted with TRIzol
Reagent (Invitrogen Corp.). After DNase treatment, 2 μg of
samples was reverse-transcribed in duplicate using Taq
polymerase and Oligo d(T)16. For RT-qPCR studies, cDNA
samples were diluted 5-fold, and for mtDNA/nDNA qPCRs,
40 ng of total genomic DNA was used. PCR amplification
and analyses were performed with StepOnePlus Real-Time
PCR Systems (Thermo Fisher). SYBR® Green PCR Master
Mix (Thermo Fisher) was used for all reactions, following
the manufacturer’s instructions. Total DNA was precipitated
with isopropanol (vol. 1 : 1) from brain tissue samples
(∼10mg), homogenized in 20mg/mL of proteinase K
solution, and finally dissolved in Tris-EDTA buffer. The
mtDNA/nDNA ratio was calculated using mtDNA primers
for the 16S rRNA and nDNA primers for the β-2 microglob-
ulin (β2M) gene [46].
2.13. Western Blots. 15 to 70 μg of protein was electropho-
resed on 10–15% vol/vol polyacrylamide SDS-PAGE gels.
Proteins were electrophoretically transferred onto PVDF
membranes. The membranes were subsequently blocked
and, after blocking, were incubated at room temperature with
the following antibodies: 1 : 500 anti-NOS1 (R-20) : sc-648,
1 : 500 anti-Mfn2 (H-68) : sc-50331, 1 : 2000 anti-actin (I-
19) : sc-1616, and 1 : 2000 anti-VDAC1 (N-18) : sc-8828 were
obtained from Santa Cruz, CA. 1 : 500 anti-OPA1 : 612607
and 1 : 1000 anti-DLP1 : 611113 were obtained from BD
Biosciences. 1 : 1000 anti-phospho-DRP1 (Ser616) : #3455
was obtained from Cell Signaling. 1 : 1000 anti-nitrotyrosine,
clone1A6 : #05-233 was obtained from EMD Millipore.
2.14. Coimmunoprecipitation. Mitochondrial proteins
(500 μg) were incubated with 4 μg of monoclonal anti-
Sirt3 antibody (C73E3) and 30 μL protein A/G PLUS Aga-
rose (Santa Cruz, CA) at 4°C. The beads were then washed
three times, suspended in sample buffer, boiled, and
centrifuged, and the supernatants were subjected to
immunoblotting against monoclonal anti-Sirt3 or anti-
nitrotyrosine, clone1A6, antibodies.
2.15. Statistical Analyses. Statistical analyses were performed
using GraphPad Prism 5.01. Data are presented as means ±
SEM, and significant differences between groups were
assessed using one-way analysis of variance (ANOVA)
followed by Bonferroni’s multiple comparison test or
Dunnett’s test [47].
3. Results
3.1. Oxidative Characteristics and ROS Production of Isolated
Brain Mitochondria Are Inversely Modified in WT and
p66Shc(−/−) Aged Mice. Aiming at understanding how p66Shc
participates in the redox homeostasis balance in aging, sev-
eral biochemical techniques were used to determine different
oxidative parameters in purified brain mitochondria from
young (3-month-old) and old (24-month-old) WT and
p66Shc−/−mice. As shown in Table 1A, there was a significant
increment inH2O2production byWTmice during aging. This
increase in the production rate varied based on the use of
malate-glutamate or succinate as the electron transport
chain (ETC) substrate, being 33% and 25%, respectively
(p < 0 05). In turn, p66Shc−/− mice exhibited a significant
reduction in total mitochondrial H2O2 production with
both substrates when compared to WT mice (41% and
26%, resp., p < 0 05) within the agedmouse groups. Concom-
itantly, superoxide generation (O2
−) and ROS production
rate, measured with MitoSOX and H2DCFDA, increased
steeply in the WT group during aging (92% and 46%, resp.,
p < 0 05) while in aged KO mice a slight rise was observed
in comparison to the young WT control group (38% and
8%, resp., p < 0 05) (Table 1B and C).
On the other hand, when the antioxidant detoxification
response was analyzed, our results showed that the loss of
MnSOD enzymatic activity registered in aging was more
pronounced in WT mice than in the aged KO group when
contrasted to the 3-month-old WT control (19% and 13%,
resp., p < 0 05). No changes were observed in catalase activity
(Table 1D and E). No differences were detected in any
parameters between WT and p66Shc−/− young mouse groups
(data not shown).
Table 1: Oxidative parameters in isolated brain mitochondria of wild-type and p66Shc(−/−) aged mice.
Control (WT 3mo) WT 24mo p66Shc(−/−) 24mo
A. H2O2 production rate (nmoles/min/mg prot)
1. Malate + glutamate 1.66± 0.05 2.22± 0.1a 0.97± 0.03b
2. Succinate 1.08± 0.05 1.35± 0.09a 0.8± 0.1b
B. Superoxide anion level (AFU) 101± 8 194± 4.5a 140± 14b
C. ROS level (AFU) 76± 3 111± 8a 82± 4a
D. SOD activity (pmoles/min/mg prot) 2824± 309 2305± 153a 2468± 94a
E. Catalase activity (units/mg prot) 32± 5 29± 4 27± 3
Note: data are expressed as themean ± SEM of the different groups (n = 6). Results were contrasted in pairs between the 3-month-oldWT control group and the
two aged groups (a) as well as between the 24-month-oldWT and p66Shc(−/−) groups (b). a and b represent p < 0 05, one-way analysis of variance (ANOVA) and
Bonferroni post hoc test.
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3.2. nNOS Activity and RNS Production Are Altered in Old
Transgenic p66Shc(−/−) Mice. Considering the low levels of
ROS production in p66Shc(−/−) aged mice and its key role in
RNS formation during aging, it was interesting to assess
how the levels of the nNOS enzyme, and its products and
byproducts, were modified in old p66Shc(−/−) mouse brains.
The absence of p66Shc did not affect nNOS gene transcription
or protein levels in the lifespan of mice. Figure 1(a) shows a
significant increase in nNOS activity of p66Shc(−/−) mice dur-
ing the latest stage of life compared to WT mice (p < 0 05).
However, a not significant increase in nNOS content was
observed in both groups during aging by Western blot and
real-time PCR (Figure 1(b)). In turn, the increase in nNOS
activity registered at 24mo observed in KO mice correlates
with the higher NO content measured at the same period
(p < 0 05) (Figure 1(c)). Interestingly, aged p66Shc−/− mice
did not exhibit the same mitochondrial protein nitration
profile as aged WT mice did. The latest showed an
increment of nitrated proteins compared to the KO
group (p < 0 05) (Figure 1(d)), consistent with the reduc-
tion in H2O2 and O2
− production, which is necessary
for the reaction with NO to form ONOO−.
3.3. Altered ROS and RNS in p66Shc KO Mice Modify Brain
Mitochondrial Metabolic Parameters in Aging. To under-
stand the effect of RNS and ROS imbalance on the mitochon-
drial function of aged p66Shc(−/−) mice, isolated and purified
brain mitochondria from both groups were used to assess
oxygen consumption in ADP stimulation (stage 3) and rest-
ing (stage 4) stages. This allowed the determination of the
respiratory control ratio (RCR = E3/E4). Table 2 shows the
bioenergetics status measured in brain mitochondria, with
malate/glutamate or succinate as oxidizable substrate.
Aging decreased the oxygen consumption rate by 25% in
stage 3 regardless of the substrate used for the WT group
(p < 0 05). However, using Mal/Glut as substrate, stage 3
of the respiratory rate was increased by 22% and 68% in
aged p66Shc(−/−) mice when compared to the 3-month-old
and 24-month-old WT groups, respectively (p < 0 05).
Meanwhile, this effect decreased by using succinate as sub-
strate with no differences observed between the aged KO
and young WT groups and only a 30% increment between
the aged KO and the aged WT groups (p < 0 05). The
respiratory control rates using both Mal/Glut and
succinate exhibited an approximate 30% inhibition in
aging (p < 0 05). In turn, 24-month-old KO mice main-
tained RCR values similar to those in 3-month-old WT
mice (Table 2A). These data suggested an inhibitory effect
on the respiratory chain by p66Shc in aged WT mouse brain.
To explain this increase in oxygen consumption rate, the
enzymatic activity of the mitochondrial respiratory chain
complexes was studied. Results showed that 24-month-old
WTmice displayed a higher decrease (48%) in complex I (CI)
activity than did aged p66Shc(−/−) mice (34%) when compared
to the 3-month-old WT control group (p < 0 05) (Table 2).
Such decrease in CI activity between the aged groups was
noticeable only in the latest stage of life while no differences
were observed between the genotypes in previous stages of life
(data not shown). Opposite to CI, higher NO concentrations,
such as the one observed in p66Shc(−/−) old mice, could be
partially responsible for the greater CIV reversible inhibition
shown in 24-month-old p66Shc(−/−)mice (31%) in comparison
with thedecrease observed inWTagingmice (17%) (p < 0 05).
Nodifferenceswereobserved inCII–III activityprofiles during
aging between both genotypes (Table 2B).
Table 2C also shows a decrease in brain tissue ATP
content for the aged WT group (65%), although such
effect was only partially reverted in aged p66Shc(−/−) mice
(35%) (p < 0 05). This was extensive to other bioenergetics
parameters. When we analyzed the NAD+/NADH ratio,
p66Shc(−/−) mice exhibited a milder decrease (32%) in com-
parison to the 78% reduction observed in the WT group
during aging while the mitochondrial membrane potential
(ΔΨ) showed a 14% decrease compared to the 49% decline
observed in the same group (p < 0 05) (Table 2D and E).
Taken together, these results indicate that aged p66Shc(−/−)
mice displayed a better mitochondrial function condition
compared than aged WT did.
3.4. Mitochondrial Content, Ultrastructure, and Morphology
Are Modified in Aged p66Shc(−/−) Mouse Brain. Based on the
improved bioenergetics parameters observed in p66Shc(−/−)
mice and the already accepted downregulated mitochondrial
biogenesis in aging, it is interesting to study how p66Shc
impacts on mitochondrial quantity and structure. The
mitochondrial content of a sample can be determined using
different methods that provide information about mitochon-
drial biogenesis and tissue’s oxidative capacity.Mitochondrial
DNA (mtDNA) content relative to nuclear DNA was deter-
mined by real-time qPCR in brain samples of the study groups
and shown as a percentage of the 3-month-old WT relative
mtDNA content. During aging, mitochondrial content was
reduced by 30% in the WT group, while in the p66Shc(−/−)
group, a 45% increase was observed (p < 0 05) (Figure 2(a)).
In accordance with these results, the PGC-1α mRNA
expression level declined by 50% inWTmouse brains during
aging, whereas in the p66Shc(−/−) group, PGC-1α remained
stable through their lives (p < 0 05) (Figure 2(b)). Electron
microscope images with fresh brain slices showed differences
in mitochondrial morphology (Figure 2(c)). For both WT
and p66Shc(−/−) 3-month-old mice, normal size and volume
mitochondria were observed, with predominantly tubular-
shaped mitochondria (70% of total measured mitochondria),
while the remaining displayed round (fragmented) morphol-
ogy. However, at the end of their life, the time point of max-
imal ROS production, 24-month-old WT mouse brain slices
were characterized by decreased tubular mitochondria
(−44%) and increased round-shaped mitochondria (+120%)
(p < 0 05). This age effect in mitochondrial morphology was
partially mitigated in 24-month-old p66Shc(−/−) mice, to the
extent that both types of mitochondrial populations coex-
isted in this group (55% tubular mitochondria) showing an
intermediate phenotype between 3- and 24-month-old WT
mice (p < 0 05) (Figure 2(d)).
3.5. The Absence of p66Shc Is Associated with Changes in
Mitochondrial Dynamics in Aging. Mitochondrial morphol-
ogy depends on the interaction among highly dynamic
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Figure 1: nNOS expression and RNS production in p66Shc(−/−) brain mice during aging. Mice were sacrificed at 3, 18, and 24 months of age.
(a) Time course of nNOS activity in mitochondria brain mice measured by 3H-L-citrulline formation (n = 6). (b) RT-qPCR and immunoblot
of proteins separated using SDS-PAGE from whole brain lysate reveals nNOS mRNA levels and protein expression of mouse brain in WT
(grey) and p66Shc(−/−) (black) groups at 3 and 24 months of age. GADPH mRNA levels and actin protein expression were used as
housekeeping control and loading control, respectively (n > 5, for each experimental group). (c) NO levels were obtained from 50 μg/mL
of isolated mitochondria incubated with 0.3mM L-arginine, 10 μM DAF-FM, and 0.5 μM MitoTracker (per duplicate) at 495 nm
(excitation) and 515 nm (emission) in the presence or absence of the NOS inhibitor (3mM L-NAME) from (n ≥ 6). (d) Western blot of
nitrated proteins from the different groups; membranes were revealed with anti-3-nitrotyrosine antibodies for each group (n ≥ 3). Values
represent means ± standard error of the mean (SEM); A represents p < 0 05 compared to the 3-month-old group, and B represents
p < 0 05 between 24-month-old WT and p66Shc(−/−) groups, one-way analysis of variance (ANOVA) and Bonferroni post hoc test.
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processes, such as the fusion/fission balance. To understand
how p66Shc intervenes in mitochondrial dynamics, we ana-
lyzed changes in some of the main proteins responsible for
the mitochondrial network remodeling. Figure 3(a) shows
that in WT mice, the Mfn2 fusion protein content in the
mitochondrial fraction decreased with aging (30%), while
p66Shc(−/−) mice exhibited a rise in the levels of this protein
(25%) (p < 0 05). Additionally, Mfn2 mRNA levels during
aging remained steady in the WT genotype while the KO
group presented a rising tendency which became signifi-
cant for the 24-month-old group (3-fold increase of con-
trol) (p < 0 05) (Figure 3(a)). Unlike Mfn2, no differences
were registered either in the Opa1 levels in the mitochon-
drial fraction of the same tissue or in its messenger
expression (Figure 3(b)). To further comprehend the effect
of p66 in the mitochondrial network, we also studied a
mitochondrial fission dynamin-related protein (Drp1).
This protein was downregulated (30%) in KO mice during
the latest stages of life, while in the WT group an upregula-
tion of Drp1 was observed during aging (50%) (p < 0 05).
An increase in p-Drp1 (S616) levels is shown in WT mice
throughout their lives (2.5-fold) (p < 0 05). However, no
changes were detected on p-Drp1 (S616) content in
p66Shc(−/−) mouse brain during aging (Figure 3(c)). The pat-
tern observed in Drp1 protein levels throughout the lives of
both WT and p66Shc(−/−) mouse groups was similar to that
of their gene expression, exhibiting a rise in aged WT mouse
brain (3-fold) and remaining stable in the p66Shc(−/−) group,
as shown in the same figure (p < 0 05).
3.6. Sirt3 Activity Is Sensitive to Being Downregulated by
Nitration. To further comprehend how the high levels of
RNS, more precisely ONOO−, can modulate the deacetylat-
ing capacity of mitochondria, we studied the biochemistry
of Sirt3, which is the main protein responsible for this
process in this organelle. Its biological activity depends on
NAD as a cofactor which increased in old p66Shc(−/−) mice
(Table 2D). Using the bioinformatics software GPS (Group-
Based Prediction System), which allowed us to predict differ-
ent posttranslational modifications, we analyzed the murine
aminoacidic sequence of Sirt3 deacetylase and detected a
tyrosine susceptible to be nitrated at position 100. Such posi-
tion has been reported to be a part of the NAD-binding
domain. With the use of a commercial kit, we tested if Sirt3
activity was sensitive to nitration. Incubating a recombinant
Sirt3 (rSirt3) with increasing concentrations of ONOO−
(100, 250, and 500 μM), we observed a decrease in the enzy-
matic activity by 47%, 55%, and 70%, respectively (p < 0 05)
(Figure 4(a)). Furthermore, the 3-nitrotyrosine content of
the Sirt3 protein immunoprecipitated from purified mito-
chondria showed a higher increase on Sirt3 nitration in the
WT group compared to the p66Shc(−/−) group during aging.
No age- or genotype-related differences were observed in
the Sirt3 expression levels measured by immunoprecipitation
assay with anti-Sirt3 antibodies (Figure 4(b)). In agreement
with these results, rSirt3 activity in the presence of the mito-
chondrial fraction from aged p66Shc(−/−) mouse brain was
higher than that observed when challenged with the aged
WT mitochondrial fraction (p < 0 05). This inhibitory effect
was equivalent to the one obtained with 100 μM ONOO−
incubation, while aged p66Shc(−/−) mitochondria with
increasedNAD/NADH ratio and reducedmitochondrial pro-
tein nitration content showed a favorable and less inhibitory
environment for rSirt3 activity (33%) (p < 0 05) (Figure 4(c)).
4. Discussion
Mitochondria play a key role maintaining cellular metabolic
homeostasis during aging [48]. In this study, we show that
brain mitochondria of p66Shc(−/−) aged mice exhibit a
Table 2: Bioenergetic parameters of isolated brain mitochondria of wild-type and p66Shc(−/−) aged mice.
Control (WT 3mo) WT 24mo p66Shc(−/−) 24mo
A. Oxygen consumption rate
1. Malate + glutamate
State 3 (ng at O/min/mg protein) 102± 3.6 74± 2.4a 125± 4.6b
Respiratory control (RC) 4.3± 0.2 3.3± 0.1a 4.4± 0.2
2. Succinate
State 3 (ng at O/min/mg protein) 116± 4.4 84± 3.5a 109± 5a
Respiratory control (RC) 4.1± 0.1 3.1± 0.1a 5± 0.1a
B. Respiratory chain complex activity
1. Complex I (nmol/min/mg protein) 78.4± 4.7 37.5± 3.1a 51.8± 5.2b
2. Complex II–III (nmol/min/mg protein) 98.2± 9.1 51.1± 6.7a 48.4± 4.1a
3. Complex IV (k′/min/mg protein) 23± 0.75 19.1± 0.45a 15.8± 1b
C. ATP synthesis rate (nmol/min/mg protein) 125± 1 42± 3a 81± 2b
D. NAD+/NADH+H ratio 5.3± 0.7 1.2± 0.4a 2.7± 0.5b
E. Mitochondrial potential, ΔΨ (AFU) 601± 15 414± 25a 520± 16b
Note: data are expressed as themean ± SEM of the different groups (n = 6). Results were contrasted in pairs between the 3-month-oldWT control group and the
two aged groups (a) as well as between both the 24-month old WT and p66Shc(−/−) groups (b). a and b represent p < 0 05, one-way analysis of variance
(ANOVA) and Bonferroni post hoc test. AFU: arbitrary fluorescence units.
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reduced alteration of redox balance and a strong link
between reactive nitrogen species and mitochondrial
function, morphology, and biogenesis [49]. We also dem-
onstrate that sirtuin 3 lysine deacetylase activity is modu-
lated by its nitration status and is enhanced by the
improved NAD+/NADH ratio observed in aged p66Shc(−/−)
brain mitochondria.
Brain mitochondria of p66Shc(−/−) aged mice exhibit a
reduced alteration of redox balance with a decrease both in
ROS generation and in its detoxification activity (Table 1),
with this balance being the major determinant of lifespan
according to Harman’s theory of aging. Although this reduc-
tion in the antioxidant response is unexpected, the upregula-
tion of this compensatory mechanismmight not be necessary
considering this low ROS production condition. Young
p66Shc−/− mouse brains show normal baseline levels of intra-
cellular oxidative stress compared to wild types, and other
groups reported the upregulation of brain p66-Shc gene
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Figure 2: Effects of aging on mitochondrial content, biogenesis, and structure in p66Shc(−/−) mouse brain. (a) Quantification of mtDNA and
nuclear DNA by qPCR. (b) The mtDNA/nDNA ratio was calculated from 3- and 24-month WT (grey) and p66Shc(−/−) (black) groups. The
mRNA levels of PGC-1α were measured in TRIzol-treated brain extracts from all the studied groups; GADPH mRNA was used as
standard (n = 6). (c) Mitochondrial morphology was evaluated using electron microscopy of fixed brain slices (n = 5 for each experimental
group) (magnification:×20,000). (d) At least 300 tubular and fragmented mitochondria were counted per arbitrary area. The percentage
distribution of tubular and fragmented brain mitochondria was determined in a minimum of 8–10 random fields at ×4400 magnification
to ensure a representative area of analysis (n = 5). Mitochondria whose length was more than three times their width were considered
tubular, while the remaining round mitochondria were considered fragmented. The analysis was performed by two different investigators
in a blinded fashion. Values represent the mean ± SEM; A represents p < 0 05 compared to the 3-month-old group, B represents p < 0 05
between 24-month-old WT and p66Shc(−/−) groups, one-way analysis of variance (ANOVA) and Bonferroni post hoc test.
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expression during aging [50]. These findings can explain the
reduced age-related oxidative stress levels observed in p66Shc
−/− mice. Therefore, p66Shc can be considered a convergent
point between both oxidative stress and programmed genetic
theories of aging.
Considerable efforts had been made to understand and
explain the effects of oxidants (ROS and RNS) on the resul-
tant oxidative-nitrosative stress on lipids, proteins, and
DNA and their contribution to the aging process. During
the last years, different groups including ours confirmed that
NO is a typical mitochondrial modulator. High levels are
harmful and end in protein oxidation and nitration, leading
to loss of mitochondrial and cell function, while controlled
levels can induce stress resistance and mitochondrial biogen-
esis [51]. Considering that mitochondrial NO metabolism
involves regulatory aspects of ROS production, RNS mark-
edly contribute to the mitochondrial modulation of life pro-
cesses [52]. Indeed, a significant nNOS increase in rat brain
during aging has been recently proven to correlate with an
increase in mitochondrial protein nitration [8]. Our findings
show an intensification in nNOS activity and high levels of
NO in p66Shc(−/−) mouse brain during aging (Figure 1). How-
ever, the rise in NO production is not followed by protein
nitration. A similar effect was previously shown in p66Shc(−/
−) mice, which are protected against age-related endothelial
dysfunction due to the increment of NO bioavailability
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Figure 3: Effects of aging on mitochondrial dynamics in p66Shc(−/−) mouse brain. Immunoblot of proteins separated using SDS-PAGE from
purified brain mitochondria or whole brain lysate and RT-qPCR of mRNA from TRIzol-treated brain extracts were performed. The
expression of the fusion proteins Mfn2 (a) and Opa1 (b), and the fission protein Drp1 (c) with its (S616) phosphorylated active isoform
and mRNA levels of mouse brain in WT (grey) and p66Shc(−/−) (black) groups were observed at 3, 18, and 24 months of age. VDAC
protein expression in mitochondrial fraction, actin protein expression in whole brain lysates, and GADPH mRNA levels in RT-qPCR were
used as standard, respectively (n > 5, for each experimental group). Values represent the mean ± SEM; A represents p < 0 05 compared to
the 3-month-old group, B represents p < 0 05 between 18- or 24-month-old WT and p66Shc(−/−) respective groups, one-way analysis of
variance (ANOVA) and Bonferroni post hoc test.
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without protein nitration [53]. This remarkable effect
observed in aged p66Shc(−/−) mice could also be caused by
their lower H2O2 and O2
− levels, disfavoring the formation
of ONOO− by NO breakdown.
Prior evidence has reported a back-and-forth communi-
cation flow between changes in ROS/RNS balance and mito-
chondrial biogenesis, dynamics, and function [10, 54, 55].
This study displays a minor decrease in the respiratory chain
complex I (CI) activity with increased oxygen consumption
and ATP content in p66Shc(−/−) compared to WT mouse
brain during aging, possibly caused by the irreversible nitra-
tion of CI at high ONOO− concentrations observed in the last
ones (Table 2) [49]. Meanwhile, the inhibition of cytochrome
c oxidase (CIV) observed in p66Shc(−/−) brain mitochondria,
possibly due to the high levels of steady-state matrix NO
concentration, is not enough to counteract this improvement
in mitochondrial bioenergetics. Even though NO binds to
and reversibly inhibits cytochrome c oxidase-modulating res-
piration, CI would own the highest level of control in brain
mitochondria ETC [56].
Sirt3 is part of the mitochondria-localized sirtuins, mod-
ulating acetylation of many proteins that participate in redox
regulation [21, 22]. One of the most interesting attributes of
Sirt3 is its potential to promote the extension of lifespan
[57, 58]. Even though the molecular basis for lifespan exten-
sion is not yet clear, the upregulation of Sirt3 expression in
long-lived individuals and its physical interaction inside
mitochondria with proteins related to the aging process, such
as FOXO3a or acetyl-coA synthetase (AceCS2), have been
indeed previously studied in literature. The FOXO family
transcription factors are human homologs of the daf-16 gene
in Caenorhabditis elegans, which contributes to the regula-
tion of the nematode lifespan [22]. Additionally, the Sirt3/
AceCS2 complex has a role in apoptosis and growth
regulation under certain environmental conditions in a spe-
cific type of noncancer epithelial cells [59].
Sirt3/PGC-1α decreased oxidative stress and conferred
resistance to oxidative stress-induced damage by regulating
antioxidant defense [60]. In aging, the gradual decline in
mitochondrial content results from an age-dependent reduc-
tion of the PGC-1α level, a key regulator ofmitochondrial bio-
genesis [61, 62]. SIRT3 mediates the reduction of the ROS
level by stimulating PGC-1α gene expression, and in turn,
PGC-1α induces SIRT3 expression, creating a positive-
feedback loop [27]. Aged p66Shc(−/−) mice show high levels
of PGC-1α gene expression and increasedmitochondrial con-
tent compared with their WT littermates (Figure 2). Accord-
ingly, an impaired balance between fission and fusion events
may also be related to an age-dependent decline in mitochon-
drial biogenesis [63].
Mitochondrial morphology depends on the interaction of
highly dynamic processes, such as the fusion/fission balance.
In aging, given the loss of plasticity of these processes, the
maintenance of metabolic homeostasis is compromised. It
has been described that ROS-induced mitochondrial depo-
larization might be responsible for mitochondrial fragmenta-
tion [64]. In this work, aged p66Shc(−/−) mouse brain
mitochondria present enhanced ΔΨ and display filament or
tubular shape. This is consistent with the observed Mfn2
upregulation, a GTPase embedded in the mitochondria outer
membrane directly involved in its fusion, and with the down-
regulation of Drp1 expression (Figure 3), a GTPase that gen-
erates ring-like structures constricting mitochondria in
fission events. Phosphorylation of Drp1 at Ser 616 (S616)
by several kinases including the cyclin-dependent kinase
(CDK) family promotes mitochondrial fission [65]. We also
observe high levels of pDrp1-S616 in WT mouse brains dur-
ing aging. These findings suggest an intimate relationship
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between mitochondrial energetic status and dynamics. More-
over, regulation of these GTPase proteins by posttransla-
tional modification, such as deacetylation by Sirt3 or
nitrosylation/nitration by RNS, is extensively described in
literature [15, 28].
Interestingly, the utilization of a GPS algorithm
predicts the existence of a tyrosine in position 100 of a
Sirt3 murine sequence which, as part of the described
NAD+-binding domain, is capable of being nitrated [66].
It is known that the decline in NAD+ level during aging
disrupts nuclear-mitochondrial communication [67]. How-
ever, the level of NAD+ remains stable in p66Shc(−/−) mice
throughout their lives. In accordance to these data, we
show here that Sirt3 is sensitive to be nitrated and its
activity is protected against age-related nitration in brains
of aged p66Shc(−/−) mice (Figure 4). These findings suggest a
close relationship between RNS and deacetylation activity
in brain mitochondria.
In accordance to the free radical theory of aging, this pro-
cess is triggered and sustained by the deleterious accumula-
tive effect of oxidative damage caused by mitochondrial
respiration-generated ROS. On the other hand, the genetic
programmed theory asserts that aging and death are neces-
sary parts of evolution, and the low variability in lifespan
within species proves that aging is not only a wear-and-tear
process [68–72]. Through its capacity to generate hydrogen
peroxide (H2O2), p66
Shc is a clear example of this strong link
between oxidative stress and the genetic of aging, and it could
be a potential target for anti-aging strategy. The modulation
of p66Shc activity could be a candidate for therapeutic inter-
vention for a longer lifespan or higher quality of life.
5. Conclusions
In conclusion, results show the pivotal role of p66Shc inacti-
vation in multiple processes related to aging in mouse brains.
Through the modification in ROS/RNS production, which in
turn regulates Sirt3 activity, the absence of p66Shc improves
mitochondrial dynamics and biogenesis. Taken together,
these findings can partially explain the observed delay in
the aging of p66Shc(−/−) mouse brains. Moreover, the
enhancement in mitochondrial homeostasis can be the
underlying cause of the improved cognition and motor func-
tion observed in p66Shc KO mice during aging [34]. More
studies will still be necessary to fully understand this complex
and multifactorial process.
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